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ABSTRACT (Maximum 200 words)
In the yeast S. cerevisiae, the CDC13 gene has been implicated in both the telomerasemediated pathway for telomere replication and in maintaining chromosome integrity. One model for Cdcl3p function at telomeres is that it functions as a single-stranded DNA binding protein and facilitates complete replication, thereby both protecting the chromosome end and potentially regulating access of telomerase to the chromosome terminus. Cdcl3p, and its binding partner, Stnlp, may be critical targets for telomere length regulation, as alterations of either gene product can confer telomere shortening or lengthening phenotypes. I found that Cdcl3p is phosphorylated in a cell-cycle dependent manner; the functional significance of the phosphorylation is not yet clear. Consistent with a role in DNA replication, Cdcl3p appears to be enriched at telomeres during active DNA replication. However, Cdcl3p may not function solely at telomeres, as it is also enriched at the centromere of chromosome III during S phase. A panel of mutant STNJ alleles should prove useful in dissecting its function as well as the nature of its interaction with Cdcl3p. 
INTRODUCTION
Telomeres, the physical ends of linear chromosomes, insulate chromosomes from end-toend fusion events, thus helping to maintain genetic stability. Telomeres, specialized structures at the ends of chromosomes, help maintain the stability of the genome and are essential for continued cell proliferation. The enzymes that replicate the genome are not capable of fully duplicating the ends of the chromosomes; thus a special mechanism is required to maintain these sequences through replicative cycles (see Nugent and Lundblad for review). In S. cerevisiae, telomere length is maintained through the aid of telomerase, a reverse transcriptase that extends the terminal GT-rich telomeric DNA strand. In order to replicate completely the chromosome end, telomerase activity is likely to be coordinated with the conventional DNA replication machinery. The goal of my research is to understand the processes involved in duplicating the chromosome ends.
Through genetic and biochemical analysis, the CDC13 gene has been suggested to encodes a protein critical for telomere replication and length regulation. In vitro, Cdcl3p binds preferentially to single-stranded G-rich oligomers (Nugent et al, Lin and Zakian) . Analysis of the cdc13-1ts allele revealed that when Cdcl3p is absent telomere proximal regions become extensively single-stranded (Garvik et al) , suggesting either that the replication of the chromosome ends is crippled, unable to properly complete lagging strand synthesis, or that the ends are subject to degradation by nucleases. The cdc13-2est allele displays a phenotype similar to that of a telomerase-defective strain, although the level of telomerase activity in vitro is normal (Nugent et al). The focus of my experiments has been to further understand the function and regulation of Cdcl3p and its interacting protein, Stnlp.
BODY L CDC13
Regulation of Cdcl3 protein
CDC13 is important for both negative and positive regulation of telomere length; thus it might be a key target for signals that modulate telomere length. To investigate whether Cdcl3p is a target of regulation, I constructed an integrated, epitope tagged version of CDC13 [CDC13myc(18x)]. The epitope tag only minimally disrupts CDC13 function. With this strain, I addressed the following questions.
Is the (steady-state) level of Cdcl3p protein cell cycle regulated? Is Cdcl3p modified during the cell cycle? Is the subcellular localization of Cdcl3p cell cycle regulated?
Cdcl3p is phosphorylated in a cell cycle dependent manner
Analysis of Cdcl3p in a time course through the cell cycle revealed that a slower electrophoretic mobility band of Cdcl3p appears as the cells traverse from G1 into S phase. The intensity of the shifted band accumulates, then disappears as the cells undergo mitosis (Fig. 1) . To determine if the slower mobility Cdc l3p resulted from phophorylation, immunoprecipitated Cdcl3p was treated with lambda phosphatase. The shifted band collapsed completely after incubation with phosphatase, suggesting Cdcl3p is modified by phosphorylation (Fig. 2) .
What is the functional significance of the phosphorylation? Phosphorylation of Cdcl3p could potentially affect Cdcl3p in a myriad of different ways. Among many possibilities, phophorylation could influence the DNA binding capacity of Cdcl3p, its association with other factors, protein stability, or subcellular localization. The most straightforward method to determine the significance of the phosphorylation would be to find the residue(s) phosphorylated in vivo, and then mutate those sites and analyze the phenotype. I chose to first analyze the ability of Cdcl3p to be phosphorylated in a number of mutant kinase strains. None of these kinasedefective strains showed a lack of Cdcl3p modification ( Table 1) . Since other genes involved in maintaining telomere length could potentially indirectly regulate the Cdcl3p modification, I also assessed the phosphorylation state of Cdcl3p in a number of different mutant backgrounds. Cdcl3p phosphorylation was not apparently altered in any mutant tested (Table 1) .
Chromatin association in arrested cells
Cdcl3p isolated from e. coli or baculovirus is capable of binding telomeric oligo substrates in vitro, suggesting that its modification is not essential for its DNA binding activity. To test whether phosphorylation affects the ability of Cdcl3p to associate with telomeric DNA in vivo, I tested whether Cdcl3p fractionates with chromatin during various stages of the cell cycle. This method fractionates the bulk of the cellular proteins from the bulk of the cellular DNA through a high speed centrifugation step (Donovan et al) . Since Cdcl3p is differentially phosphorylated through the cell cycle, I hoped to determine if its association with DNA in vivo correlated with its phosphorylation state. Under the conditions of the assay used, no association with DNA was detected under any of the arrest conditions imposed. Later experiments in which Cdcl3p was crosslinked to DNA in vivo suggest that the chromatin association of Cdcl3p may be sensitive to hydroxyurea, the drug used to synchronize cells in S phase. (see below) Therefore, I will repeat the fractionation experiments to determine if phosphorylated or unphosphorylated Cdcl3p associates with chromatin during S phase.
Sedimentation
To address the possibility that the phosphorylation state of Cdcl3p affects its association with other factors, I tested whether Cdcl3p sedimented as part of different sized complexes in G1 (where phosphorylation of Cdcl3p is minimal) or pre-anaphase (where phosphorylation of Cdcl3p is maximal) arrested cells. The sedimentation profile of Cdcl3p in glycerol gradients was similar comparing extracts from GI arrested or pre-anaphase arrested cells. This data does not rule out the possibility that Cdcl3p transiently or loosely associates with different factors at these different cell cycle points. I plan to repeat this experiment to determine if Cdcl3p sediments as part of a large complex during S phase.
Immunofluorescence
Cdcl3p appears to be localized in the nucleus throughout the cell cycle, as determined by indirect immunofluorescence. To the detection limit of this method, there is no correlation between the cell cycle stage (phosphorylation) and Cdcl3p localization.
Unpublished Data
In vivo crosslinking of Cdcl3p
Cdcl3p is associated with telomeres in a cell cycle dependent manner
To test the hypothesis that Cdcl3p specifically associates with telomeric DNA in vivo, the formaldehyde cross-linking method (ChIP) was employed (Aparicio et al, Meluh and Koshland) . This method allows the assessment of the relative amounts of DNA sequences that immunoprecipitate with the protein of interest after treating cells with formaldehyde, a chemical that reacts with amino and imido groups of proteins and of nucleic acids such that protein-DNA, protein-RNA, and protein-protein crosslinks form between molecules in close proximity (2A) (Orlando et al) . Given the data suggesting Cdcl3p is regulated in some manner by phosphorylation, crosslinking of Cdcl3p to DNA was analyzed in cell cycle synchronized cells. The amount of telomeric DNA (GI_ 3 T) associated with Cdcl3p IPs (immunoprecipitations) was enriched during S phase, consistent with a role for Cdcl3p in replication of telomeres ( Figure  3A ). To determine if Cdcl3p crosslinks specifically to telomeres, the immunoprecipitated DNA was analyzed for sequences corresponding to regions along the right arm of chromosome V, as well as for the centromeres of chromosomes III and V. Interestingly, the centromere of chromosome III showed a cell cycle dependent enrichment of DNA in the IP similar to the telomeric DNA, whereas none of the other regions probed were greatly enriched in the IPs at any point in the cell cycle ( Figure 3B ). The significance of the association with CEN3 sequences is not currently understood; Cdcl3p does not appear to be a general centromere associated protein since it does not crosslink similarly to CEN5 and CDC13 mutants do not display phenotypes suggestive of a specific requirement at centromeres.
Experiments are currently in progress to further understand the regulation of the association of Cdcl3p with DNA. Preliminary data suggests that the crosslinking of Cdcl3 to telomeres and CEN3 is sensitive to hydroxyurea (HU), a drug that inhibits progression through S-phase. Recent data suggests that treatment of S. cerevisiae with HU results in the prevention of firing late origins (Santocanale and Diffley, Shirahige et al.) . Thus, the HU sensitivity of the Cdcl3p association with telomeres, regions known to replicate late, is consistent with a role for Cdcl3p at telomeres during the process of replication. It is possible that a low level of Cdcl3p is constitutively associated with telomeric DNA, and is only enriched at telomeres during replication when more single-stranded substrate is available for binding. Further information concerning how other proteins influence Cdcl3p DNA binding in vivo will come from analysis of Cdc I3p crosslinking in mutant backgrounds.
Exploring the nature of the defect in the cdc13-2est allele Data from two-hybrid experiments suggest that the cdc13-2est mutation disrupts interaction with STN]. To more fully understand the in vivo ramifications of the mutation, I epitope tagged mutant cdcl3-2est protein and found that neither its protein level nor modification throughout the cell cycle are substantially different from the wild-type protein. Preliminary data, however, suggests that the in vivo DNA association of cdc13-2eSt may deviate from wild-type protein.
Unpublished Data
II. STNI
Characterization of STN1
STNJ was originally identified in a screen for low copy suppressors of the temperature sensitivity of cdc13-1ts cells (Grandin et al) . In addition, it was identified in my screen for Cdcl3 interacting proteins. The low copy suppression and Cdcl3p two-hybrid interaction data suggest that Stnlp and Cdcl3p may function as a complex. STN1 is essential for viability, although its precise function is not known and its sequence reveals no recognizable motifs. High copy expression of STNJ can lead to telomere shortening whereas mutant STNJ alleles can display extremely elongated telomeres (Grandin et al, Table 2 ), suggesting that STN1, like CDC13, is required for proper telomere length regulation. Both genetic and biochemical approaches are being undertaken in order to understand the role of Stnlp in telomere replication. I have generated mutant STN1 alleles by random PCR mutagenesis as well as by site directed mutagenesis (alanine scanning). These mutant alleles are currently being characterized (Table  2) ; one goal is to identify an allele that will be useful for identifying additional gene products that interact with STNJ. Shirahige, K., Hori, Y., Shiraishi, K., Yamashita, M., Takahashi, K., Obuse, C., Tsurimoto, T., and H. Yoshikawa. 1998. Regulation of DNA-replication origins during cell-cycle progression. Nature 395:618-621.
Figure Legends Cdcl3p is phosphorylated. Cdcl3(myc) 18 immunoprecipitates from nocodazole arrested cells were treated as indicated at 30'C for 45 minutes. The 6% SDS-PAGE gel was blotted and the western probed with 9E10 (anti-myc). (Nocodazole treatment arrests cells preanaphase.) Figure 3 .
(A.) Cdcl3p crosslinking to telomeres and CEN3 is enriched during S phase of the cell cycle. Untagged or Cdcl3(myc), 8 strains were synchronized in G1 through arrest with alpha factor, then released; samples were taken at intervals, treated with formaldehyde for 1 hour, and processed as described in Aparicio et al. The 9E10 antibody (anti-myc) was used for the immunoprecipitations. The amount of particular DNA sequences in the immunoprecipitate and input DNA samples was determined by dot blot hybridization. The values plotted represent the fraction of a sequence in the Cdc13(myc) 18 strain immunoprecipitate versus the fraction of that sequence in the untagged strain immunoprecipitate. (B.) Cdcl3p crosslinking is not enriched during S phase at other genomic regions. The immunoprecipitates shown in (A) were probed for sequences at the HMR region of chromosome III, at the RAD24 locus 40 kb distal from the telomere of chromosome VR, and the centromere of chromosome V. Cdc 13p phosphorylation was assessed by determining if the mobility shift pattern on SDS-PAGE was similar to wild-type cells. The phosphorylation state of Cdcl3p in the checkpoint related kinase and telomere replication defective strains was assayed in cells arrested with nocodazole.
In the strains defective for cell cycle related kinases, Cdcl3p was analyzed either in asynchronous cultures incubated at temperatures that should inactivate the kinase (a) or in cultures released from an alpha-factor block at restrictive temperature (b). Time after release from alpha-factor (main)
Unpublished Data Telomere length in many immortal eukaryotic cell populations is maintained at least in part through the action of telomerase, a reverse transcriptase that extends the terminal GT-rich telomeric DNA strand. However, telomerase alone is not responsible for maintaining the length and integrity of chromosome ends. In the yeast S. cerevisiae, the CDC13 gene has been implicated in both the telomerase-mediated pathway for telomere replication and in maintaining telomere integrity. One current model for Cdcl3p function is that it associates with telomeres as a single-stranded binding protein and facilitates complete replication of the telomeres by both protecting the chromosome end and regulating access of telomerase to the chromosome terminus.
To further explore the role of CDC13 in telomere replication, we identified two CDC13-interacting proteins through a yeast two-hybrid screen. One of these proteins interacts in the two-hybrid assay not only with CDC13, but also with EST2, the catalytic subunit of telomerase. Although deletion of this novel gene does not lead to perturbations of telomere length, preliminary analysis indicates that there may be some genetic interactions with CDC13; further characterization of the function of this gene may reveal some insight into the regulation of telomere replication. The second CDC13-interacting protein identified was STN1, a gene isolated by M. Charbonneau's lab as a suppressor of the cdc13-1ts mutant. In order to understand the role of the Cdcl3p/Stnlp complex in telomere replication, experiments are in progress to assess the regulation of these proteins throughout the cell cycle as well as the association of these proteins with chromosome ends in vivo. Current data suggests that Cdcl3- Telomere length in many immortal eukaryotic cells is maintained in part through the action of telomerase, a reverse transcriptase that extends the terminal GT-rich telomeric DNA strand. However, telomerase alone is not responsible for maintaining the length and integrity of chromosome ends. In the yeast S. cerevisiae, the CDC13 gene has been implicated both in the telomerase-mediated pathway for telomere replication and in maintaining telomere integrity. One model for Cdc 13p function is that it associates with telomeres as a single-stranded DNA binding protein and facilitates complete replication of the telomeres, thereby both protecting the chromosome end and regulating access of telomerase to the chromosome terminus. To further test this model, I am analyzing the in vivo association of Cdcl3p with chromatin to determine both the cell-cycle timing and sequence specificity of its binding.
CDC13 may be a critical target for telomere length regulation, as mutant alleles have been identified that confer telomere shortening or lengthening phenotypes. I have shown that Cdcl3p is phosphorylated in a cell-cycle dependent manner, with phosphorylated protein appearing during S phase and accumulating prior to completion of mitosis. Experiments are progress to ascertain both the phosphorylated residue(s) and the functional significance of this phosphorylation.
Using a two-hybrid screen, I identified STN1 as a CDC13-interacting protein, a gene also isolated by M. Charbonneau's lab as a high-copy suppressor of the cdcl3-1 mutant. The inability of the senescent cdc13-2est allele to interact with STN1 in the two-hybrid assay suggests that Stnlp may be critical for proper Cdcl3p function in telomere replication. I am characterizing additional stnl mutant alleles, as well as isolating dosage suppressors of temperature-sensitive stnl alleles to further elucidate the role of STN1 at telomeres.
